BioNTech, CureVac bag $745M in German funding for COVID-19 vaccine hopefuls
Two German biotechs, BioNTech and CureVac, have been at the cutting edge of the hunt for a COVID-19 vaccine—a ...
- Latest
Two German biotechs, BioNTech and CureVac, have been at the cutting edge of the hunt for a COVID-19 vaccine—a ...
A few weeks after the groundbreaking budget agreement adopted by the European Council on July 21, 2020, it would...
Read more
